When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio's PRV-031 Breakthrough Therapy for individuals at risk type 1 diabetes
Provention Bio Inc.
The FDA has granted Breakthrough Therapy Designation (BTD) to Provention Bio's (NASDAQ:PRVB) teplizumab (PRV-031) for the prevention or delay of clinical type 1 diabetes in individuals at-risk of developing the disease.
More news on: Provention Bio, Inc., Healthcare stocks news, Stocks on the move,